CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Camurus AB Company Snapshot
Camurus AB operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Camurus AB with three other companies in this sector in SWEDEN : Swedencare AB (publ) (2020 sales of 240.30 million Swedish Kronor [US$28.33 million] of which 54% was PRODEN PLAQUEOFF), Enzymatica AB (publ) (111.25 million Swedish Kronor [US$13.11 million] of which 100% was Medical Devices), and Oasmia Pharmaceutical AB (201.84 million Swedish Kronor [US$23.79 million] of which 100% was Licensing revenues).

Sales Analysis. Sales increased substantially in 2020: During the year ended December of 2020, sales at Camurus AB were SEK 336.00 million (US$39.61 million). This is an increase of 218.2% versus 2019, when the company's sales were SEK 105.61 million. Sales of Sales of Development Related Goods and S saw an increase of 347.4% in 2020, from SEK 72.08 million to SEK 322.53 million. Not all segments of Camurus AB experienced an increase in sales in 2020: sales of License and Milestone Revenues fell 83.3% to SEK 4.43 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Camurus AB
  Stock Performance Chart for Camurus AB
 
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 214.00
(Figures in Swedish Kronor)
1 Week 2.1%   13 Weeks 1.4%  
4 Weeks 4.4%   52 Weeks 76.9%  
 
Camurus AB Key Data:
  Ticker: CAMX Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 335,997,000
(Year Ending Jan 2021).
Employees: 134
  Currency: Swedish Kronor Market Cap: 11,606,027,422
  Fiscal Yr Ends: December Shares Outstanding: 54,233,773
  Share Type: Aktie Closely Held Shares: 29,652,336
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.